- The Weed Blog https://www.theweedblog.com

THC Skin Cream Can Combat Allergies


thc marijuana cannabis skin allergiesCourtesy of The Joint Blog

new study being published the journal Allergy has found that THC skin cream can combat certain allergies, in part because it has anti-inflammatory capabilities.

According to researchers, “Topical THC application effectively decreased contact allergic ear swelling and myeloid immune cell infiltration not only in wild-type but also in CB1/2 receptor-deficient mice.”

For the study – which was funded by the German Research Council and the University of Bonn’s Medical Faculty - researchers “evaluated the impact of topically applied THC on DNFB-mediated allergic contact dermatitis in wild-type and CB1/2 receptor-deficient mice”. Researchers conclude:

Topically applied THC can effectively attenuate contact allergic inflammation by decreasing keratinocyte-derived pro-inflammatory mediators that orchestrate myeloid immune cell infiltration independent of CB1/2 receptors. This has important implications for the future development of strategies to harness cannabinoids for the treatment of inflammatory skin diseases.

Although the study was conducted on mice, Thomas Tüting, MD – one of the researchers for the study – tells us that he believes the results would be similar if the subjects were human.

As with most studies – regardless of how solid the evidence – more research is needed to validate these findings. However, the results of the study are more than promising, and thousands of patients have already found success in using cannabis skin creams to treat a wide number of conditions; the science is now starting to catch up.

Source: TheJointBlog.Com


About Author

Johnny Green


  1. GravityChanges on

    That they hold a patent on for:

    “Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases.The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”

    The patent was obtained in October of 2003.


  2. But – But – But – my government says this is a schedule 1 DRUG with NO Medicinal uses….

Leave A Reply